Iodothyronine compositions
US7163918B2 · kind B2 · utility
18Cited by
92References
25Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 2, 2002 |
| Grant date | Jan 16, 2007 |
| Priority date | — |
| Expiry date | Jul 28, 2023 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K47/62
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention relates to compositions comprising thyroxine (T4) and triiodothyronine (T3). More specifically, the invention relates to thyroxine (T4) and triiodothyronine (T3) compositions that include a peptide carrier and thyroxine (T4) and triiodothyronine (T3) covalently attached to at least one of the N-terminus, the C-terminus, a side chain of the peptide carrier, and/or interspersed within the peptide chain; methods for protecting and administering thyroxine (T4) and triiodothyronine (T3); and methods for treating thyroid disorders.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.